Astera Labs, Inc. $ALAB Holdings Raised by Hsbc Holdings PLC

Hsbc Holdings PLC lifted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 128.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 83,721 shares of the company’s stock after acquiring an additional 47,081 shares during the quarter. Hsbc Holdings PLC’s holdings in Astera Labs were worth $14,126,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Reflection Asset Management bought a new stake in Astera Labs during the fourth quarter valued at $25,000. Smartleaf Asset Management LLC lifted its position in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Hilltop National Bank boosted its holdings in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the period. Aventura Private Wealth LLC bought a new stake in shares of Astera Labs during the 4th quarter valued at about $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new stake in Astera Labs during the fourth quarter worth about $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insiders Place Their Bets

In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the transaction, the director directly owned 4,631 shares of the company’s stock, valued at $2,083,950. The trade was a 66.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the company’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the sale, the general counsel directly owned 103,343 shares of the company’s stock, valued at $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 2,164,441 shares of company stock valued at $526,198,280. 10.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

ALAB has been the subject of a number of research reports. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Rothschild & Co Redburn started coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target on the stock. Stifel Nicolaus boosted their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Citigroup downgraded Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Finally, Royal Bank Of Canada increased their target price on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $265.75.

Astera Labs Price Performance

Astera Labs stock opened at $382.89 on Wednesday. Astera Labs, Inc. has a 12-month low of $88.18 and a 12-month high of $499.48. The stock has a market capitalization of $65.63 billion, a PE ratio of 258.71, a price-to-earnings-growth ratio of 4.97 and a beta of 3.66. The firm has a 50 day simple moving average of $322.82 and a 200-day simple moving average of $209.73.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.